Amina Jumamyradova

Amina Jumamyradova

Auto-generated profile, based on publicly available information

Amina Jumamyradova

Department of Neuroscience, Developmental and Regenerative Biology, The University of Texas at San Antonio, San Antonio, TX 78249, USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2025 in Data in Brief
Verified
Journal Article
Open access
CCCameron M. Chapa
Cameron M. Chapa
DFDustin R. Fetch
Dustin R. Fetch
AJAmina A. Jumamyradova
Amina A. Jumamyradova
ASAlexey A. Soshnev
Alexey A. Soshnev
Mouse embryonic stem cells (mESCs) represent an exceptional model for understanding how transcriptional responses are regulated by signalling pathways during development. Treatment with a cocktail of MEK and GSK3β inhibitors (“2i”) induces ground state pluripotency, characterized by increased self-renewal, reduced DNA methylation, and uniformly high expression of pluripotency markers. Polycomb Repressive Complex 2 (PRC2) is a key developmental regulator controlling stem cell self-renewal and differentiation decisions, and altered expression of PRC2 target genes is a signature of 2i-mediated ground state conversion. Here, we generated a comprehensive RNA sequencing dataset from mESCs subjected to 2i conversion time-course across five time points between 0 and 96 h. We analysed two independently derived wild type lines, and two isogenic Cas9-edited lines carrying loss-of-function mutations in core PRC2 subunits Enhancer of Zeste Homolog 2 (Ezh2) or Embryonic Ectoderm Development (Eed). These data provide a resource to understand the temporal patterns of transcriptional responses to MEK and GSK3β inhibitors and explore the role of PRC2 function in regulation of pluripotency circuit.

12 June 2025 in bioRxiv
Verified
Preprint
Open access
HSHarry Siegel
Harry Siegel
CHCreehan Healy
Creehan Healy
KGKrystal Goyins
Krystal Goyins
AJAmina Jumamyradova
Amina Jumamyradova
JYJie Ying
Jie Ying
LBLacy J Barton
Lacy J Barton
Precise control of hormones is essential to development and reproduction. Hormone bioavailability is regulated by their synthesis and transport, as well as sequestration, natural turnover, and programmed degradation. Here, we use Drosophila melanogaster to investigate developmentally programmed degradation of the retinoic acid-like Juvenile hormones (JHs) that functionally oppose the steroid hormone, ecdysone. Elevated JH titers promote growth and prevent metamorphosis. To understand the role of programmed JH degradation, we generated double and triple knockout animals lacking one of two classes of JH degradation enzymes: JH esterases (JHEs) and JH epoxide hydrolases (JHEHs). While both classes of enzymes degrade JHs, we found they have separate developmental functions such that JHEs restrain growth while JHEHs support growth and ensure timely metamorphosis. To investigate the nature of these unique developmental requirements, we performed genetic and hormone rescue experiments, analyzed hormone-producing glands, and characterized dysregulated gene networks by RNA-sequencing. Together, these data revealed unique dysregulated networks consistent with the separate developmental requirements, as well as shared regulation of Cytochrome P450 gene expression and the size of the ecdysone-producing gland. Strikingly, the four-day delay in metamorphosis in the absence of JHEHs is rescued by ecdysone despite increased ecdysone synthesis gene expression and larger glands in these animals. Together, this study provides new genetic tools and insights into the complexities of programmed hormone degradation in development.

11 July 2025 in NAR Molecular Medicine
Verified
Journal Article
Open access
DFDustin R Fetch
Dustin R Fetch
AJAmina Jumamyradova
Amina Jumamyradova
CCCameron M Chapa
Cameron M Chapa
YGYong Ge
Yong Ge
MMMansour Mohamadzadeh
Mansour Mohamadzadeh
ASAlexey A Soshnev
Alexey A Soshnev
Multicellular organisms arise from a single genome template in the zygote, necessitating the cells of the developing embryo to up- and downregulate specific genes to establish and maintain their identity. This template is maintained, propagated, and interpreted as chromatin, a polymer of nucleic acids and associated structural and regulatory proteins. Recent genome-wide surveys documented a wealth of disease-associated mutations in chromatin factors, indicating their fundamental significance and potential for therapeutic targeting. However, chromatin factors exist in a complex balance, with a single deficiency often leading to pleiotropic downstream effects. Here, we review the mechanisms of chromatin regulation and partitioning, highlighting examples of how these processes are altered in human diseases. We argue that loss of chromatin fidelity, both locally at specific genes and regulatory elements, and globally at the megabase-scale, contributes to many pathological states and may thus represent an intriguing target for corrective interventions.